0000899243-23-011196.txt : 20230412 0000899243-23-011196.hdr.sgml : 20230412 20230412164707 ACCESSION NUMBER: 0000899243-23-011196 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230410 FILED AS OF DATE: 20230412 DATE AS OF CHANGE: 20230412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brannan Stephen K. CENTRAL INDEX KEY: 0001777631 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38958 FILM NUMBER: 23816180 MAIL ADDRESS: STREET 1: C/O KARUNA THERAPEUTICS, INC. STREET 2: 33 ARCH STREET, SUITE 3110 CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karuna Therapeutics, Inc. CENTRAL INDEX KEY: 0001771917 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270605902 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-449-2244 MAIL ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-10 0 0001771917 Karuna Therapeutics, Inc. KRTX 0001777631 Brannan Stephen K. C/O KARUNA THERAPEUTICS, INC. 99 HIGH STREET, 26TH FLOOR BOSTON MA 02110 0 1 0 0 Chief Medical Officer 1 Common Stock 2023-04-10 4 M 0 5000 9.20 A 28650 D Common Stock 2023-04-10 4 S 0 5000 176.88 D 23650 D Option (right to buy) 9.20 2023-04-10 4 M 0 5000 0.00 D 2029-03-20 Common Stock 5000 6362 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 8, 2022 This option vests as to 12.5% of the shares underlying the option award on each six month anniversary following the vesting commencement date of March 21, 2019. /s/ Troy Ignelzi, Attorney-in-Fact 2023-04-12